Pdl Biopharma Inc (PDLI)

Cost of Revenue

$0.00

Quarterly · Period ending: · USD

PDLI logo

PDLI Cost of Revenue

Latest reported$0.00
PDLI Quarterly Cost of Revenue (-$800.00K → $0.00)
High-resolution chart · PNG

PDLI cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Pdl Biopharma Inc Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
0
2,639,000
2,860,000
13,428,000
15,033,000
12,348,000
12,810,000
11,444,000
11,926,000
14,524,000
10,566,000
17,905,000
5,565,000
4,515,000
2,552,000
4,065,000
0
0
0
0
0
0
0
0
0
0
11,931,000
5,637,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
16,801,000
18,549,000
24,998,000
24,418,000
17,433,000
21,482,000
22,959,000
16,776,000
22,209,000
20,135,000
1,137,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-1,302,000
-962,000
-1,083,000
-851,000
-800,000
-900,000
-900,000
-900,000
-1,100,000
-900,000
-900,000
-800,000
-800,000
-800,000
-800,000
-800,000
-800,000
-800,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.